Clinical Trial Update: Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the effects of esketamine on acute abdominal pain after transarterial chemoembolization in hepatocellular carcinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Pain

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization | Phase 4 | Status: UNKNOWN